» Authors » Franciszek Kasprzykowski

Franciszek Kasprzykowski

Explore the profile of Franciszek Kasprzykowski including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 24
Citations 138
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Dzierzynska M, Sawicka J, Deptula M, Sosnowski P, Sass P, Peplinska B, et al.
Sci Rep . 2023 Apr; 13(1):6273. PMID: 37072464
Self-assembling peptides can be used for the regeneration of severely damaged skin. They can act as scaffolds for skin cells and as a reservoir of active compounds, to accelerate scarless...
2.
Fidor A, Cekala K, Wieczerzak E, Ceglowska M, Kasprzykowski F, Edwards C, et al.
Biomolecules . 2021 Oct; 11(10). PMID: 34680116
Nostocyclopeptides (Ncps) are a small class of bioactive nonribosomal peptides produced solely by cyanobacteria of the genus . In the current work, six Ncps were isolated from strain CCNP1411. The...
3.
Karska N, Graul M, Sikorska E, Slusarz M, Zhukov I, Kasprzykowski F, et al.
Chem Biodivers . 2021 Jan; 18(2):e2000883. PMID: 33427369
Herpesviruses are the most prevalent viruses that infect the human and animal body. They can escape a host immune response in numerous ways. One way is to block the TAP...
4.
Deptula M, Karpowicz P, Wardowska A, Sass P, Sosnowski P, Mieczkowska A, et al.
Adv Wound Care (New Rochelle) . 2020 Oct; 9(12):657-675. PMID: 33124966
This study evaluated the use of novel peptides derived from platelet-derived growth factor (PDGF-BB) as potential wound healing stimulants. One of the compounds (named PDGF2) was subjected for further research...
5.
Zebrowska J, Jezewska-Frackowiak J, Wieczerzak E, Kasprzykowski F, Zylicz-Stachula A, Skowron P
Appl Microbiol Biotechnol . 2019 Mar; 103(8):3439-3451. PMID: 30879089
Over 470 prototype Type II restriction endonucleases (REases) are currently known. Most recognise specific DNA sequences 4-8 bp long, with very few exceptions cleaving DNA more frequently. TsoI is a...
6.
Dzierzynska M, Sikorska E, Pogorzelska A, Mulkiewicz E, Sawicka J, Wyrzykowski D, et al.
Protein Pept Lett . 2019 Mar; 26(6):423-434. PMID: 30864495
Background: Antibacterial peptidyl derivative - Cystapep 1, was previously found to be active both against antibiotic-resistant staphylococci and streptococci as well as antibioticsusceptible strains of these species. Therefore, it is...
7.
Karska N, Graul M, Sikorska E, Zhukov I, Slusarz M, Kasprzykowski F, et al.
Biochim Biophys Acta Biomembr . 2019 Feb; 1861(5):926-938. PMID: 30772281
The transporter associated with antigen processing (TAP) directly participates in the immune response as a key component of the cytosolic peptide to major histocompatibility complex (MHC) class I protein loading...
8.
Behrendt I, Pradzinska M, Spodzieja M, Czaplewska P, Kolodziejczyk A, Szymanska A, et al.
J Mol Recognit . 2017 Dec; 31(4). PMID: 29205549
Amyloid formation is associated with a number of neurodegenerative diseases that affect the independence and quality of life of aging populations. One of rather atypical, occurring at a young age...
9.
Stralberg F, Kassem A, Kasprzykowski F, Abrahamson M, Grubb A, Lindholm C, et al.
J Leukoc Biol . 2017 Feb; 101(5):1233-1243. PMID: 28196851
Inflammation-induced bone destruction is a major treatment target in many inflammatory skeletal diseases. The aim of this study was to investigate if the cysteine proteinase inhibitors cystatin C, fungal cysteine...
10.
Pikula M, Smuzynska M, Krzystyniak A, Zielinski M, Langa P, Deptula M, et al.
Bioorg Med Chem . 2017 Jan; 25(4):1431-1439. PMID: 28110818
A peptidomimetic called A20 (Cystapep 1) structurally based upon the N-terminal fragment of human cystatin C is known to have strong antibacterial properties. A20 is characterized by high activity against...